Trillium Therapeutics Inc
Officers & Directors
Executive team:
- Jan Skvarka, President and Chief Executive Officer: Mr. Skvarka has over 25 years of experience in the biotechnology industry, including executive leadership roles at several companies. He joined Trillium in 2020.
- Leonard Kruimer, Chief Financial Officer: Mr. Kruimer has over 20 years of experience in finance and accounting, including leadership roles in corporate finance and investment banking. He joined Trillium in 2018.
- Robert Uger, Chief Scientific Officer and Head of Research and Development: Dr. Uger has over 20 years of experience in the biopharmaceutical industry, including leadership roles in research and development at several companies. He joined Trillium in 2018.
Board of directors:
- Jane A. T. Hsiao, Chair of the Board: Dr. Hsiao has over 30 years of experience in the biotechnology industry, including co-founding several companies. She is also a board member of several other biotech companies.
- Henry Ji, Director: Dr. Ji has over 25 years of experience in the biopharmaceutical industry, including executive leadership roles at several companies. He is also a board member of several other biotech companies.
- John Kavanagh, Director: Mr. Kavanagh has extensive experience as a corporate director and executive in the pharmaceutical, biotechnology, and medical device industries.
Trillium Therapeutics Inc currently has 41 employees.
|
